Latest Stock Market Summary & Market Quotes

Market Quotes

Latest DVAX Analysis

David Sterman | November 20, 2013

After a tumultuous year for this biotech, key hurdles are being conquered, and the next catalysts could unlock triple-digit gains.

Michael J. Carr... | February 15, 2013

This small-cap biotech is expecting a ruling from the FDA on a promising new drug in the next few days. If the news is good, this trade could land you a big payday.